Response assessment criteria, such as RANO, struggle to distinguish between true progression and pseudoprogression. In this work we evaluated the performance of radiomic texture features extracted from MR perfusion images (Dynamic contrast enhancement (DCE) and Dynamic susceptibility contrast (DSC)) in discriminating true progression from pseudoprogression. Using a large multi-institutional cohort, we demonstrated that changes in texture features of perfusion maps (DCE and DSC) can be effective predictors of progressive disease. We present a noninvasive, complimentary method that is directly applicable in clinical setting and can assist physicians in diagnosis and therapy planning.
This abstract and the presentation materials are available to members only; a login is required.